Beyond BRCA1/2: Homologous Recombination Repair Genetic Profile in a Large Cohort of Apulian Ovarian Cancers.

Background: Pathogenic variants in homologous recombination repair (HRR) genes other than have been associated with a high risk of ovarian cancer (OC). In current clinical practice, genetic testing is generally limited to . Herein, we investigated the mutational status of both and 5 HRR genes in 69 unselected OC, evaluating the advantage of multigene panel testing in everyday clinical practice.